Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Regency Centers Corp (REG): Hedge Funds Are Buying, Should You?

Page 1 of 2

Before we spend many hours researching a company, we’d like to analyze what hedge funds and billionaire investors think of the stock first. We would like to do so because the elite investors’ consensus returns have been exceptional. The top 30 S&P 500 stocks among hedge funds at the end of September 2014 yielded an average return of 9.5% during the last 12 months ending in October 30. Sixty three percent of these 30 stocks outperformed the market. Although the elite funds occasionally have their duds, such as Micron and Anadarko Petroleum, which fell 50% and 26%, respectively during the same time period, the hedge fund picks seem to work on average. In the following paragraphs, we find out what the billionaire investors and hedge funds think of Regency Centers Corp (NYSE:REG).

Is Regency Centers Corp (NYSE:REG) worth your attention right now? Prominent investors are taking a bearish view. The number of bullish hedge fund bets shrunk by 2 lately. Regency Centers Corp (NYSE:REG) was in 7 hedge funds’ portfolios at the end of September. There were 9 hedge funds in our database with Regency Centers Corp (NYSE:REG) holdings at the end of the previous quarter. At the end of this article, we will also compare Regency Centers Corp (NYSE:REG) to other stocks, including Columbia Pipeline Group Inc (NYSE:CPGX), Lamar Advertising Co (NASDAQ:LAMR), and A. O. Smith Corporation (NYSE:AOS) to get a better sense of its popularity.

Follow Regency Centers Corp
Trade (REG) Now!

To most stock holders, hedge funds are seen as underperforming, outdated investment tools of the past. While there are greater than 8000 funds with their doors open today, We hone in on the top tier of this group, approximately 700 funds. These money managers control the bulk of the hedge fund industry’s total capital, and by watching their matchless stock picks, Insider Monkey has brought to light a number of investment strategies that have historically outrun the broader indices. Insider Monkey’s small-cap hedge fund strategy outrun the S&P 500 index by 12 percentage points per year for a decade in their back tests.

Now, let’s take a gander at the fresh action encompassing Regency Centers Corp (NYSE:REG).

What does the smart money think about Regency Centers Corp (NYSE:REG)?

At the end of Q3, a total of 7 of the hedge funds tracked by Insider Monkey held long positions in this stock, a drop of 22% from the previous quarter. With hedge funds’ positions undergoing their usual ebb and flow, there exists an “upper tier” of noteworthy hedge fund managers who were increasing their holdings substantially (or already accumulated large positions).

When looking at the institutional investors followed by Insider Monkey, Millennium Management, managed by Israel Englander, holds the most valuable position in Regency Centers Corp (NYSE:REG). Millennium Management has a $39.7 million position in the stock, comprising 0.1% of its 13F portfolio. On Millennium Management’s heels is Citadel Investment Group, managed by Ken Griffin, which holds a $4.6 million position; less than 0.1% of its 13F portfolio is allocated to the company. Hedge funds and other institutional investors that are bullish encompass Cliff Asness’ AQR Capital Management, Greg Poole’s Echo Street Capital Management, and Renaissance Technologies.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!